Accordingly, we also noted significant decreases in IL-10 and GM-CSF, along with a favorable trend in TNFα levels.
← all excerpts
Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
1
—
—
Accordingly, we also noted significant decreases in IL-10 and GM-CSF, along with a favorable trend in TNFα levels.